Chemours/$CC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Chemours
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Ticker
$CC
Sector
Primary listing
NYSE
Employees
6,000
Headquarters
Website
Chemours Metrics
BasicAdvanced
$1.9B
-
-$2.75
1.63
$0.68
2.71%
Price and volume
Market cap
$1.9B
Beta
1.63
52-week high
$21.72
52-week low
$9.13
Average daily volume
3.1M
Dividend rate
$0.68
Financial strength
Current ratio
1.676
Quick ratio
0.789
Long term debt to equity
1,802.51
Total debt to equity
1,845.607
Interest coverage (TTM)
1.30%
Profitability
EBITDA (TTM)
664
Gross margin (TTM)
18.34%
Net profit margin (TTM)
-7.04%
Operating margin (TTM)
6.00%
Effective tax rate (TTM)
-50.55%
Revenue per employee (TTM)
$980,000
Management effectiveness
Return on assets (TTM)
2.98%
Return on equity (TTM)
-85.27%
Valuation
Price to revenue (TTM)
0.331
Price to book
8.15
Price to tangible book (TTM)
10.22
Price to free cash flow (TTM)
-35.815
Free cash flow yield (TTM)
-2.79%
Free cash flow per share (TTM)
-0.36
Dividend yield (TTM)
5.23%
Forward dividend yield
2.71%
Growth
Revenue change (TTM)
0.62%
Earnings per share change (TTM)
-489.89%
3-year revenue growth (CAGR)
-5.50%
10-year revenue growth (CAGR)
-0.34%
3-year earnings per share growth (CAGR)
-19.91%
10-year earnings per share growth (CAGR)
8.95%
3-year dividend per share growth (CAGR)
-5.74%
What the Analysts think about Chemours
Analyst ratings (Buy, Hold, Sell) for Chemours stock.
Bulls say / Bears say
Chemours and DuPont agreed to pay a combined $671 million to settle C-8 lawsuits, with Chemours’s share $300 million below Wall Street estimates—an outcome that drove a 13% jump in Chemours shares on resolution of key legacy liabilities (Reuters)
Appointment of long‐time company insider Jonathan Lock as CFO brings financial leadership with proven experience in executing strategic divestitures, suggesting potential for improved capital allocation and operational focus (Reuters)
The August agreement to settle New Jersey PFAS claims for $875 million—with Chemours’s 50% share having a pre-tax present value of about $500 million—provides clarity and caps legacy PFAS liabilities, reducing overhang on future earnings (Reuters)
Dutch court ruling holds Chemours liable for PFAS-related environmental damage in the Netherlands, exposing it to potential further litigation and remediation costs across Europe (Reuters)
Under the New Jersey settlement, Chemours must pay 50% of the $875 million over 25 years—representing a present value of approximately $500 million before taxes—adding substantial long-term cash obligations and pressure on liquidity (Reuters)
The abrupt replacement of longtime CFO Sameer Ralhan with insider Jonathan Lock, announced without public explanation, raises concerns over potential governance issues and executive distraction amid legal challenges (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
Chemours Financial Performance
Revenues and expenses
Chemours Earnings Performance
Company profitability
Chemours News
AllArticlesVideos
Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call
Business Wire2 days ago
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
MarketBeat2 weeks ago
Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Chemours stock?
Chemours (CC) has a market cap of $1.9B as of October 18, 2025.
What is the P/E ratio for Chemours stock?
The price to earnings (P/E) ratio for Chemours (CC) stock is 0 as of October 18, 2025.
Does Chemours stock pay dividends?
Yes, the Chemours (CC) stock pays dividends to shareholders. As of October 18, 2025, the dividend rate is $0.675 and the yield is 2.71%. Chemours has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Chemours dividend payment date?
The next Chemours (CC) dividend payment date is unconfirmed.
What is the beta indicator for Chemours?
Chemours (CC) has a beta rating of 1.63. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.